Cargando...
Reducing Episodic Cluster Headaches: Focus on Galcanezumab
The involvement of calcitonin gene-related peptide in migraine and cluster headache has led to the recent development of new therapies. Galcanezumab, a novel monoclonal antibody targeting the calcitonin gene-related peptide, is approved for the migraine prevention and has recently been tested for th...
Gardado en:
| Publicado en: | J Pain Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342329/ https://ncbi.nlm.nih.gov/pubmed/32753938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S222604 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|